Molecular diagnostics platform automating PCR testing across clinical settings
Cepheid operates a portfolio of molecular diagnostic systems (GeneXpert and Xpert tests) spanning infectious disease, oncology, and genetic testing. The company is mid-migration to SAP S/4HANA while maintaining heavy infrastructure-as-code tooling (Terraform, CloudFormation, Ansible, Chef, Puppet) and CI/CD across AWS and Azure — typical of a regulated medical-device firm scaling ops and compliance automation. Active hiring skews toward engineering and senior roles, with projects focused on next-generation instrument firmware, diagnostic software, and cross-functional data-to-application workflows.
Notable leadership hires: Facilities Director, Market Access Director, Marketing Director, Director Product Management
Cepheid is a public diagnostic-instruments company (part of Danaher) headquartered in Sunnyvale, California, with 5,001–10,000 employees. The company manufactures and distributes GeneXpert automated PCR systems and a broad Xpert test portfolio covering respiratory infections, TB, blood virology, women's health, oncology, and genetic testing — products used in central labs, hospitals, and near-patient settings. Operations span multiple countries: the United States, India, Sweden, South Africa, Malaysia, Singapore, Portugal, Spain, Malawi, and Saudi Arabia. Core challenges center on new-product development, firmware and system regulatory compliance, product reliability, and claims processing.
Cepheid uses Salesforce for CRM, SAP (including S/4HANA, Fiori, BTP, and GRC) for enterprise resource planning, AWS and Azure for cloud infrastructure, Terraform and CloudFormation for infrastructure-as-code, and GitLab CI/CD, Jenkins, and Azure DevOps for deployment pipelines.
Cepheid actively recruits across ten countries: United States, India, Sweden, South Africa, Malaysia, Singapore, Portugal, Spain, Malawi, and Saudi Arabia.
Other companies in the same industry, closest in size